Source: ISNA, Tehran
Iran is going to make non-carcinogenic "docetaxel" by end of Iranian calendar year which ends on March 19, saving 40 million dollars annually.
Docetaxel is a very expensive drug used to cure lung, head and neck, and breast cancers. The medicine is said to cost 40 percent lower comparing to its foreign version.
Iran has already mass-produced Doxorubicin -- another non-carcinogenic drug - used in lung and breast cancer cases and was made based on nano-liposomes technique. The drug with higher efficiency needs lower times for use and naturally lessens side-effects including vascular and heart complications.
"We are the second producer of the medicine in the world and we hope the patients would face less problems after using the medication," said the deputy of Iranian food and drug organization for drug affairs.
Iran is also producing two other non-carcinogenic medicines Paclitaxel for breast and ovarian cancer and oxaliplatin for colon cancer.
... Payvand News - 03/25/16 ... --